Carson Wealth (CWM LLC)’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
AIM
FCM
VPM
AVM
VCM
NAMA
Carson Wealth (CWM LLC)'s BEAM Position: Q1 2026 in Review
Carson Wealth (CWM LLC) increased its Beam Therapeutics (BEAM) stake by 77% in Q1 2026, buying an estimated $52.7K and bringing the position to 4,364 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #3234.
Carson Wealth (CWM LLC) first reported a position in BEAM in Q1 2022 and has held it in 17 quarters since. The position peaked at $1.7M in Q3 2022. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.
- Carson Wealth (CWM LLC) held 4,364 shares of Beam Therapeutics worth $104K as of Q1 2026.
- Carson Wealth (CWM LLC) bought 1,898 Beam Therapeutics shares in Q1 2026, an estimated $52.7K.
- Beam Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3234 holding.
- Carson Wealth (CWM LLC) first reported a position in Beam Therapeutics in Q1 2022 and has held it in 17 quarters since.
- Carson Wealth (CWM LLC)'s Beam Therapeutics position peaked at $1.7M in Q3 2022.
- 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.
Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.